PE20120571A1 - Produccion de titulos elevados de polivirus para la produccion de vacunas - Google Patents
Produccion de titulos elevados de polivirus para la produccion de vacunasInfo
- Publication number
- PE20120571A1 PE20120571A1 PE2012000051A PE2012000051A PE20120571A1 PE 20120571 A1 PE20120571 A1 PE 20120571A1 PE 2012000051 A PE2012000051 A PE 2012000051A PE 2012000051 A PE2012000051 A PE 2012000051A PE 20120571 A1 PE20120571 A1 PE 20120571A1
- Authority
- PE
- Peru
- Prior art keywords
- poliovirus
- production
- cells
- polivirus
- titles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
- C12N7/02—Recovery or purification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32651—Methods of production or purification of viral material
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Biomedical Technology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Abstract
UN PROCESO PARA PRODUCIR UN POLIOVIRUS QUE COMPRENDE PROVEER UN CULTIVO DE CELULAS PER.C6 EN UNA SUSPENSION LIBRE DE SUERO, INFECTAR DICHAS CELULAS CON POLIOVIRUS EN UNA DENSIDAD CELULAR DE ENTRE 2X106 CELULAS/ML Y 150X106 CELULAS/ML Y COSECHAR LOS POLIOVIRUS ENTRE 12 Y 48 HORAS DESPUES DE LA INFECCION. EL POLIOVIRUS ES LA CEPA MAHONEY DEL POLIOVIRUS DEL TIPO 1, LA CEPA MEF DEL POLIOVIRUS DEL TIPO 2 O LA CEPA SAUKETT DEL POLIOVIRUS DEL TIPO 3. TAMBIEN ESTA REFERIDA A UNA VACUNA CONTRA LA POLIO QUE COMPRENDE A DICHO POLIOVIRUS, PURIFICADO Y OPCIONALMENTE, INACTIVADO
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US27103809P | 2009-07-16 | 2009-07-16 | |
EP09165620 | 2009-07-16 |
Publications (1)
Publication Number | Publication Date |
---|---|
PE20120571A1 true PE20120571A1 (es) | 2012-06-06 |
Family
ID=41412431
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PE2012000051A PE20120571A1 (es) | 2009-07-16 | 2010-07-08 | Produccion de titulos elevados de polivirus para la produccion de vacunas |
Country Status (33)
Country | Link |
---|---|
US (4) | US8546123B2 (es) |
EP (1) | EP2454364B1 (es) |
JP (1) | JP5845178B2 (es) |
KR (1) | KR101548790B1 (es) |
CN (1) | CN102482647B (es) |
AP (1) | AP3140A (es) |
AR (1) | AR077314A1 (es) |
AU (1) | AU2010272685B2 (es) |
BR (1) | BR112012000942B8 (es) |
CA (1) | CA2763091C (es) |
CO (1) | CO6491042A2 (es) |
CU (1) | CU20120006A7 (es) |
DK (1) | DK2454364T3 (es) |
EA (1) | EA020563B1 (es) |
ES (1) | ES2484093T3 (es) |
HK (1) | HK1164922A1 (es) |
HR (1) | HRP20140597T1 (es) |
IL (1) | IL217465A (es) |
MA (1) | MA33429B1 (es) |
MX (1) | MX2011012648A (es) |
MY (1) | MY183385A (es) |
NZ (1) | NZ596880A (es) |
PE (1) | PE20120571A1 (es) |
PL (1) | PL2454364T3 (es) |
PT (1) | PT2454364E (es) |
RS (1) | RS53377B (es) |
SG (1) | SG177655A1 (es) |
SI (1) | SI2454364T1 (es) |
SM (1) | SMT201400079B (es) |
TN (1) | TN2011000628A1 (es) |
TW (1) | TWI477606B (es) |
WO (1) | WO2011006823A1 (es) |
ZA (1) | ZA201108271B (es) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2647985C (en) | 2006-03-31 | 2014-12-30 | Warf-Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses for vaccines |
US9474798B2 (en) | 2007-06-18 | 2016-10-25 | Wisconsin Alumni Research Foundation | Influenza M2 protein mutant viruses as live influenza attenuated vaccines |
BRPI0921651A2 (pt) | 2008-11-03 | 2015-08-18 | Crucell Holland Bv | Método para produzir adenovírus recombinante, e partículas virais, e, biorreator |
SG177655A1 (en) | 2009-07-16 | 2012-02-28 | Crucell Holland Bv | Production of polio virus at high titers for vaccine production |
US9109013B2 (en) | 2009-10-26 | 2015-08-18 | Wisconsin Alumni Research Foundation | High titer recombinant influenza viruses with enhanced replication in vero cells |
US10130697B2 (en) | 2010-03-23 | 2018-11-20 | Wisconsin Alumni Research Foundation (Warf) | Vaccines comprising mutant attenuated influenza viruses |
AU2014215025B2 (en) | 2013-02-05 | 2018-08-30 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Cell lines for virus production and methods of use |
WO2014135651A1 (en) | 2013-03-08 | 2014-09-12 | Crucell Holland B.V. | Acellular pertussis vaccine |
WO2014142433A1 (ko) | 2013-03-13 | 2014-09-18 | 고려대학교산학협력단 | 바이러스 생산능이 증가된 세포주 및 그 제조방법 |
KR20140112255A (ko) | 2013-03-13 | 2014-09-23 | 고려대학교 산학협력단 | 바이러스 생산능이 증가된 세포주 및 그 제조방법 |
GB201305361D0 (en) | 2013-03-25 | 2013-05-08 | Univ Edinburgh | Enhanced expression |
RS57864B1 (sr) | 2013-06-17 | 2018-12-31 | De Staat Der Nederlanden Vert Door De Minister Van Vws Ministerie Van Volksgezondheid Welzijn En Spo | Postupci za sprečavanje agregacije virusnih komponenti |
JP2016524915A (ja) | 2013-07-15 | 2016-08-22 | ウィスコンシン アルムニ リサーチ ファンデイション | Mdck、ベロ細胞又は卵内で増強された複製を有する高力価の組換えインフルエンザウイルス |
US20160053281A1 (en) * | 2013-08-15 | 2016-02-25 | The University Court Of The University Of Edinburgh | Enhanced Expression Of RNA Vectors |
CN106232800B (zh) | 2014-03-25 | 2020-07-03 | 泰尔茂比司特公司 | 介质的被动替代 |
AU2015276235B2 (en) | 2014-06-17 | 2021-02-18 | Janssen Vaccines & Prevention B.V. | Cold-Adapted-Viral-Attenuation (CAVA) and novel attenuated Poliovirus strains |
US10526393B2 (en) | 2014-06-18 | 2020-01-07 | Immunomax Co., Ltd. | Method for promoting virus infection and increasing virus production, by using cell line having lost BST2 gene functions |
US10053671B2 (en) | 2014-06-20 | 2018-08-21 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to additional genes in influenza viruses |
EP3172317B1 (en) | 2014-07-24 | 2019-05-01 | Janssen Vaccines & Prevention B.V. | Process for the purification of poliovirus from cell cultures |
US10633422B2 (en) | 2015-06-01 | 2020-04-28 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication by inhibiting microRNA lec7C binding to influenza viral cRNA and mRNA |
WO2017004592A1 (en) | 2015-07-02 | 2017-01-05 | Terumo Bct, Inc. | Cell growth with mechanical stimuli |
US9890363B2 (en) | 2015-07-06 | 2018-02-13 | Wisconsin Alumni Research Foundation (Warf) | Influenza virus replication for vaccine development |
JP2019510481A (ja) | 2016-02-19 | 2019-04-18 | ウィスコンシン アルムニ リサーチ ファンデイション | ワクチン開発のための改善されたb型インフルエンザウイルス複製 |
WO2017205667A1 (en) | 2016-05-25 | 2017-11-30 | Terumo Bct, Inc. | Cell expansion |
US11104874B2 (en) | 2016-06-07 | 2021-08-31 | Terumo Bct, Inc. | Coating a bioreactor |
US11685883B2 (en) | 2016-06-07 | 2023-06-27 | Terumo Bct, Inc. | Methods and systems for coating a cell growth surface |
US10372100B2 (en) * | 2016-08-29 | 2019-08-06 | Ge Healthcare Bio-Sciences Corp. | Manufacturing system for biopharmaceutical products |
CN110612344B (zh) | 2017-03-31 | 2023-09-12 | 泰尔茂比司特公司 | 细胞扩增 |
CN107723279B (zh) * | 2017-10-18 | 2020-11-10 | 成都远睿生物技术有限公司 | 一种缺陷型腺病毒AdC68-GP的培养方法 |
WO2019155492A1 (en) * | 2018-02-07 | 2019-08-15 | Bharat Biotech International Limited | A process for enterovirus purification and inactivation and vaccine compositions obtained thereof |
US11241492B2 (en) | 2019-01-23 | 2022-02-08 | Wisconsin Alumni Research Foundation (Warf) | Mutations that confer genetic stability to genes in influenza viruses |
US11851648B2 (en) | 2019-02-08 | 2023-12-26 | Wisconsin Alumni Research Foundation (Warf) | Humanized cell line |
WO2020223699A1 (en) | 2019-05-01 | 2020-11-05 | Wisconsin Alumni Research Foundation (Warf) | Improved influenza virus replication for vaccine development |
WO2020229581A1 (en) | 2019-05-16 | 2020-11-19 | Janssen Vaccines & Prevention B.V. | Methods for inducing a safe immune response against polio virus |
WO2021041624A2 (en) | 2019-08-27 | 2021-03-04 | Yoshihiro Kawaoka | Recombinant influenza viruses with stabilized ha for replication in eggs |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4525349A (en) * | 1981-12-29 | 1985-06-25 | Societe Anonyme Dite: Institut Merueux | Process for the large-scale production of a vaccine against poliomyelitis and the resulting vaccine |
EP0833934B2 (en) | 1995-06-15 | 2012-08-15 | Crucell Holland B.V. | Packaging systems for human recombinant adenovirus to be used in gene therapy |
US7521220B2 (en) * | 1999-11-26 | 2009-04-21 | Crucell Holland B.V. | Production of vaccines |
EP1103610A1 (en) | 1999-11-26 | 2001-05-30 | Introgene B.V. | Production of vaccines from immortalised mammalian cell lines |
US6544424B1 (en) | 1999-12-03 | 2003-04-08 | Refined Technology Company | Fluid filtration system |
EP1256803A1 (en) | 2001-05-07 | 2002-11-13 | Crucell Holland B.V. | Methods for the identification of antiviral compounds |
AU2003288273A1 (en) * | 2002-10-23 | 2004-05-13 | Crucell Holland B.V. | New settings for recombinant adenoviral-based vaccines |
NZ539813A (en) * | 2002-12-17 | 2008-04-30 | Crucell Holland Bv | A replication defective recombinant adenovirus comprising a antigenic determinant of Plasmodium falciparum wherein the antigenic determinant is SEQ ID 6 |
CN101328473B (zh) * | 2003-05-09 | 2012-05-02 | 克鲁塞尔荷兰公司 | E1-永生化的细胞培养物及培养所述细胞以提高从中获取的产物产量的方法 |
CN1930281A (zh) | 2004-03-05 | 2007-03-14 | 帝斯曼知识产权资产管理有限公司 | 用于通过连续灌注和交互切向流来培养细胞的方法 |
EA010057B1 (ru) | 2004-08-27 | 2008-06-30 | Панацея Биотек Лтд. | Инактивированная полиомиелитная вакцина, полученная из штамма сейбина вируса полиомиелита |
ATE523205T1 (de) * | 2004-10-14 | 2011-09-15 | Crucell Holland Bv | Prime-boost-impfstoffe gegen malaria |
CN100500827C (zh) * | 2004-11-26 | 2009-06-17 | 中国医学科学院医学生物学研究所 | 用人胚肺二倍体细胞培养繁殖脊髓灰质炎病毒的方法 |
US20100144620A1 (en) * | 2006-11-16 | 2010-06-10 | Crucell Holland B.V. | Complementation of factor xi deficeincy by factor v mutants |
SG177655A1 (en) * | 2009-07-16 | 2012-02-28 | Crucell Holland Bv | Production of polio virus at high titers for vaccine production |
KR20120070015A (ko) | 2010-12-21 | 2012-06-29 | (주)창조바이오텍 | 알파-피넨을 유효성분으로 포함하는 스쿠티카충 구제용 조성물 |
-
2010
- 2010-07-08 SG SG2012002705A patent/SG177655A1/en unknown
- 2010-07-08 MX MX2011012648A patent/MX2011012648A/es active IP Right Grant
- 2010-07-08 ES ES10729895.2T patent/ES2484093T3/es active Active
- 2010-07-08 PT PT107298952T patent/PT2454364E/pt unknown
- 2010-07-08 EP EP10729895.2A patent/EP2454364B1/en active Active
- 2010-07-08 CA CA2763091A patent/CA2763091C/en active Active
- 2010-07-08 AP AP2012006075A patent/AP3140A/xx active
- 2010-07-08 MA MA34534A patent/MA33429B1/fr unknown
- 2010-07-08 NZ NZ596880A patent/NZ596880A/xx not_active IP Right Cessation
- 2010-07-08 RS RS20140325A patent/RS53377B/en unknown
- 2010-07-08 JP JP2012519981A patent/JP5845178B2/ja active Active
- 2010-07-08 DK DK10729895.2T patent/DK2454364T3/da active
- 2010-07-08 KR KR1020127001501A patent/KR101548790B1/ko active IP Right Grant
- 2010-07-08 MY MYPI2012000173A patent/MY183385A/en unknown
- 2010-07-08 CN CN201080026814.2A patent/CN102482647B/zh active Active
- 2010-07-08 PL PL10729895T patent/PL2454364T3/pl unknown
- 2010-07-08 EA EA201270173A patent/EA020563B1/ru not_active IP Right Cessation
- 2010-07-08 AU AU2010272685A patent/AU2010272685B2/en not_active Ceased
- 2010-07-08 SI SI201030661T patent/SI2454364T1/sl unknown
- 2010-07-08 WO PCT/EP2010/059796 patent/WO2011006823A1/en active Application Filing
- 2010-07-08 BR BR112012000942A patent/BR112012000942B8/pt not_active IP Right Cessation
- 2010-07-08 PE PE2012000051A patent/PE20120571A1/es active IP Right Grant
- 2010-07-14 AR ARP100102556A patent/AR077314A1/es active IP Right Grant
- 2010-07-15 TW TW099123327A patent/TWI477606B/zh not_active IP Right Cessation
- 2010-07-16 US US12/804,242 patent/US8546123B2/en active Active
-
2011
- 2011-11-10 ZA ZA2011/08271A patent/ZA201108271B/en unknown
- 2011-12-07 TN TNP2011000628A patent/TN2011000628A1/en unknown
-
2012
- 2012-01-10 IL IL217465A patent/IL217465A/en active IP Right Grant
- 2012-01-13 CU CU2012000006A patent/CU20120006A7/es unknown
- 2012-01-16 CO CO12005515A patent/CO6491042A2/es unknown
- 2012-05-31 HK HK12105337.7A patent/HK1164922A1/xx not_active IP Right Cessation
- 2012-10-25 US US13/660,412 patent/US20130052224A1/en not_active Abandoned
-
2013
- 2013-03-15 US US13/843,052 patent/US20130273106A1/en not_active Abandoned
-
2014
- 2014-05-12 US US14/275,392 patent/US9022240B2/en active Active
- 2014-06-24 SM SM201400079T patent/SMT201400079B/xx unknown
- 2014-06-26 HR HRP20140597AT patent/HRP20140597T1/hr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PE20120571A1 (es) | Produccion de titulos elevados de polivirus para la produccion de vacunas | |
AR069956A1 (es) | Procesos para cultivar celulas mamiferas secretoras de proteinas sanguineas heterologas | |
HN2011001446A (es) | Compuesto utiles para inhibir chk1 | |
UA112768C2 (uk) | Європейський штам prrsv | |
CL2015002128A1 (es) | Sistema integrado de reactor anaerobio metanogénico y biorreactor de membranas para la eliminación de materia orgánica y nitrógeno en aguas residuales. | |
CO6290704A2 (es) | Virus de la estomatitis vesicular (vsv) atenuado y geneticamente modificado y composiciones inmunogenicas que lo contienen. | |
AR079039A1 (es) | Membranas compuestas de silicona de gran poder separador | |
WO2014123967A3 (en) | Cell lines for virus production and methods of use | |
AR095354A1 (es) | Métodos para el armado de bancos celulares de alta densidad | |
AR084715A1 (es) | Fermentador para fermentar biomasa | |
CL2012002871A1 (es) | Metodo para identificar una población de celulas tr1 en reposo que comprende la deteccion de la expresion en la superficie celular de los marcadores cd4, cd25, cd127 y cd62l; poblacion aislada de celulas tr1; metodo para disminuir una poblacion de celulas tr1; kit para identificar o aislar una poblacion de celulas tr1 en reposo y/o activadas; composicion farmaceutica que comprende una poblacion de celulas tr1 en reposo y/o activadas. | |
MX2013005140A (es) | Medios de cultivo de celulas granulados en seco. | |
AR097981A1 (es) | Interferencia de la represión del factor de transcripción hd-zip de expresión génica para la producción de plantas con rasgos mejorados | |
CL2008003821A1 (es) | Metodo para producir el virus de la estomatitis vesicular (vsv) atenuado en celulas, que comprende: a) proporcionar una celula que comprende un gen g vsv optimizado e inducible, b) inducir la celula a expresar dicho gen, c) infectar la celula con un vsv atenuado, d) hacer crecer dichas celulas, y e) recuperar el vsv atenuado | |
TR201902192T4 (tr) | Bir rüzgar türbini kanadı. | |
AR058810A1 (es) | Linea celular vero adaptada para crecer en suspension | |
AR092630A1 (es) | Metodos y composiciones para prevenir la incorporacion erronea de norleucina en proteinas | |
EA201270577A1 (ru) | Усовершенствованные способы обратной генетики для спасения вирусов | |
GB0503172D0 (en) | Detection method | |
ES2351296B8 (es) | Cepas de s. cerevisiae capaces de crecer en medios con melibiosa, estaquiosa y rafinosa. | |
BRPI0914805B8 (pt) | método para replicar vírus em uma cultura de células scldk, processo para adaptar células cldk dependentes do substrato para desenvolvimento em suspensão, método para propagar continuamente células scldk em suspensão, e, composição | |
DK2368572T3 (da) | Adjuvansvacciner med ikke-virionantigener fremstillet fra influenza-virusser dyrket i cellekultur | |
ES2479540T3 (es) | Células, construcciones de ácidos nucleicos, células que comprenden dichas construcciones y métodos de utilización de dichas células en el tratamiento de enfermedades | |
AR092688A1 (es) | Metodos y composiciones para aumentar la resistencia a nematodos en plantas | |
RU2009127971A (ru) | Средство для повышения репродуктивности самок нутрии и жизнеспособности приплода |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant, registration |